Circ Pharma recognises the need for strong intellectual property and technology to support its product pipeline and enhance the commercial prospects of its product candidates. With this in mind Circ Pharma has developed a comprehensive intellectual property portfolio to protect its products both in the US and major markets internationally.
Circ Pharma has over 13 issued or pending US patents and patent applications and their related international counterparts.
This intellectual property is focused on synchronising drug exposure to the circadian patterns of disease - specifically to the periods of highest risk or need - or to underlying physiological functions - specifically the optimal site of absorption. As a result, we take a rational or targeted approach to designing formulations of drugs to optimally treat disease and provide significant incremental patient benefits.
Circ Pharma has over 13 issued or pending US patents and patent applications and their related international counterparts.
This intellectual property is focused on synchronising drug exposure to the circadian patterns of disease - specifically to the periods of highest risk or need - or to underlying physiological functions - specifically the optimal site of absorption. As a result, we take a rational or targeted approach to designing formulations of drugs to optimally treat disease and provide significant incremental patient benefits.